Literature DB >> 6169370

Quantitative aspects of the formation and loss of DNA interstrand crosslinks in Chinese hamster cells following treatment with cis-diamminedichloroplatinum(II) (cisplatin). II. Comparison of results from alkaline elution, DNA renaturation and DNA sedimentation studies.

M F Pera, C J Rawlings, J Shackleton, J J Roberts.   

Abstract

The formation of interstrand crosslinks in the DNA of cis-diamminedichloroplatinum(II) (cisplatin)-treated Chinese hamster cells has been demonstrated by three independent, highly sensitive techniques: namely those of alkaline elution, renaturation of crosslinked DNA and alkaline sucrose gradient velocity sedimentation. Simultaneous measurement of DNA break frequency by the first two methods and a computer model combined with the third enabled the calculation of crosslink frequency after application of low doses of cisplatin. Good agreement was found between the values obtained by the three methods used here, and also with those obtained by direct measurement of the amount of crosslinked hybrid DNA in density-labelled cells treated with higher doses of cis-platin (Roberts, J.J. and Friedlos, F. (1981) Biochim. Biophys, Acta 655, 146--151). When measured by all three methods described here, crosslinking was found to increase during several hours after treatment and then to decrease with a half-life of between 12 and 24 h. For low initial levels of crosslinking, this was largely attributed to an excision repair process, since the formation of breaks in DNA was only minimal.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169370     DOI: 10.1016/0005-2787(81)90005-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  A new assay for functional screening of BRCA2 linker region mutations identifies variants that alter chemoresistance to cisplatin.

Authors:  Curtis R Warren; Zohra Ali-Khan Catts; Mary C Farach-Carson
Journal:  Exp Cell Res       Date:  2011-06-29       Impact factor: 3.905

Review 2.  Drug resistance and DNA repair.

Authors:  M Fox; J J Roberts
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 3.  Mechanisms of cellular resistance to cisplatin.

Authors:  G A Hospers; N H Mulder; E G De Vries
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

Review 4.  The evolving role of DNA inter-strand crosslinks in chemotherapy.

Authors:  Halley B Rycenga; David T Long
Journal:  Curr Opin Pharmacol       Date:  2018-04-18       Impact factor: 5.547

5.  Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.

Authors:  M C Poirier; S J Lippard; L A Zwelling; H M Ushay; D Kerrigan; C C Thill; R M Santella; D Grunberger; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

6.  The effects of boron containing peptides on L1210 lymphoid leukemia metabolism.

Authors:  I H Hall; E S Hall; M C Miller; A Sood; B F Spielvogel
Journal:  Amino Acids       Date:  1993-10       Impact factor: 3.520

7.  Cytotoxicity of boron containing dipeptide analogs.

Authors:  S Karthikeyan; A Sood; J Tomasz; B F Spielvogel; I H Hall
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

8.  Cellular pharmacology of novel C8-linked anthramycin-based sequence-selective DNA minor groove cross-linking agents.

Authors:  M Smellie; L R Kelland; D E Thurston; R L Souhami; J A Hartley
Journal:  Br J Cancer       Date:  1994-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.